The REVEAL Study

The Risk Evaluation and Education for Alzheimer’s Disease (REVEAL) Study, funded by NIH, was the first ever study to disclose APOE Alzheimer’s Disease risk to healthy patients and made important contributions to the scientific understanding of disclosing genetic risk for Alzheimer’s Disease.Through a series of multi-site randomized controlled clinical trials, REVEAL provided empirical data to address ethical, … Continued

Publications

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2006

2005

2004

2003

2002

2001

2000

1998

1997

1995

Latest News From Genomes2People